Delivery Order SPE2DB22D9239-SPE2DB24FDK64

Award Date 6/27/24
Potential Completion Date 6/28/24
Potential Value $47K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $47,362.64, is for the delivery of 4564742782 Jakafi 10 mg tablet 60s. This order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group, valued at up to $499,999,999, which allows the DLA to issue firm fixed-price delivery orders for a comprehensive...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The order, valued at $71,043.96, is for the delivery of Jakafi 10 mg tablets over the period ending on May 7, 2024. DMS Pharmaceutical Group holds a significant single-award indefinite delivery contract (IDC) with DLA, valued at up to $499,999,999, which allows the agency to issue firm fixed-price delivery...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $12,146.79, is for the delivery of Jakafi 5 mg tablets. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the DLA to issue firm fixed-price delivery orders for a...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of the pharmaceutical product Jakafi 15 mg tablet 60s, with a completion date of April 30, 2024, and a ceiling value of $11,773.87. DMS Pharmaceutical Group Inc. holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $23,690.47 contract is for the delivery of Jakafi 5 mg tablets. DMS Pharmaceutical Group holds a larger indefinite delivery contract with DLA, valued up to $4,999,999 through 2025, which enables the agency to issue firm fixed-price delivery orders for a broad range of pharmaceutical...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business organization. The $47,399.24 contract provides the DLA with Jakafi 5 mg tablets over a period ending on April 4, 2024. This delivery order is part of a larger $4,999,999 indefinite delivery vehicle (IDV) contract, SPE2DB, held by DMS Pharmaceutical Group to supply a broad range of pharmaceutical products to military health...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $12,115.65, is for the delivery of 60 tablets of the prescription drug Jakafi 10 mg. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between DMS Pharmaceutical Group and the DLA, valued at $499,999,999 and valid through November...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $11,840.66 contract is for the delivery of Jakafi 10 mg tablets and does not have a set-aside designation. DMS Pharmaceutical Group Inc. holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue firm fixed-price...
This is a federal delivery order contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, by the Defense Logistics Agency (DLA) to provide Jakafi 10 mg tablets. The contract has a ceiling value of $23,681.32 and a period of performance through March 26, 2024. DMS Pharmaceutical Group holds a separate indefinite delivery contract with DLA, valued up to $4,999,999 through 2025, to provide a broad range of pharmaceutical items to military health facilities worldwide. This...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $11,840.66 contract is to provide the branded pharmaceutical product Jakafi 10 mg tablets to support the recurring medical supply needs of military health facilities. DMS Pharmaceutical Group holds a larger $499,999,999 indefinite delivery contract (IDC) with DLA under the SPE2DB...
  • SPE2DB22D9239
    Indefinite Delivery Contract
  • SPE2DB22D9239-SPE2DB24FDK64
    Delivery Order

This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the supply of the pharmaceutical product Jakafi 10 mg tablets. The contract has a ceiling value of $47,362.64 and a period of performance through June 28, 2024.

DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDC) with the DLA, valued up to $499,999,999, that allows the agency to issue delivery orders for a comprehensive range of pharmaceutical items to support the medical supply needs of military health facilities worldwide. This delivery order is placed against that overarching IDC vehicle. The contract does not have a set-aside designation.

Generated 9/26/24, 9:25 AM